Cytek Biosciences to Report Third Quarter 2022 Financial Results on November 9, 2022GlobeNewsWire • 10/26/22
Cytek to Participate in the 20th Annual Morgan Stanley Global Healthcare ConferenceGlobeNewsWire • 08/30/22
Cytek Biosciences, Inc. (CTKB) CEO Wenbin Jiang on Q2 2022 Results Earnings Call TranscriptSeeking Alpha • 08/11/22
Cytek Biosciences Vs. 10x Genomics: 2 Opposing Cell Visualization InvestmentsSeeking Alpha • 07/27/22
Cytek to Participate in the 42nd Annual Canaccord Genuity Global Growth ConferenceGlobeNewsWire • 07/21/22
Cytek Biosciences to Report Second Quarter 2022 Financial Results on August 10, 2022GlobeNewsWire • 07/20/22
Cytek® Biosciences Receives CE Marking for Series of cFluor® Reagents, TBNK KitGlobeNewsWire • 05/24/22
Cytek Biosciences, Inc. (CTKB) CEO Wenbin Jiang on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/12/22
Cytek Biosciences, Inc.'s (CTKB) CEO Wenbin Jiang on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 02/24/22
Cytek Biosciences Reports Fourth Quarter and Full Year 2021 Financial ResultsGlobeNewsWire • 02/23/22
Cytek Biosciences to Report Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022GlobeNewsWire • 02/11/22
Cytek® Biosciences Expands Fremont Headquarters, Tripling Its Manufacturing CapacityGlobeNewsWire • 01/05/22
Cytek Biosciences, Inc. (CTKB) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?Zacks Investment Research • 11/25/21